Zacks Research Has Positive Outlook for MTD FY2024 Earnings

Mettler-Toledo International Inc. (NYSE:MTDFree Report) – Equities research analysts at Zacks Research lifted their FY2024 EPS estimates for shares of Mettler-Toledo International in a research note issued on Thursday, November 28th. Zacks Research analyst R. Department now anticipates that the medical instruments supplier will earn $40.40 per share for the year, up from their previous forecast of $40.28. The consensus estimate for Mettler-Toledo International’s current full-year earnings is $40.42 per share. Zacks Research also issued estimates for Mettler-Toledo International’s Q2 2025 earnings at $10.34 EPS, FY2025 earnings at $42.39 EPS, Q3 2026 earnings at $11.88 EPS and FY2026 earnings at $48.78 EPS.

Mettler-Toledo International (NYSE:MTDGet Free Report) last posted its quarterly earnings results on Thursday, November 7th. The medical instruments supplier reported $10.21 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $10.00 by $0.21. Mettler-Toledo International had a negative return on equity of 531.78% and a net margin of 21.15%. The company had revenue of $954.54 million for the quarter, compared to analyst estimates of $941.93 million.

Several other brokerages have also commented on MTD. Stifel Nicolaus dropped their price target on shares of Mettler-Toledo International from $1,550.00 to $1,450.00 and set a “buy” rating on the stock in a research note on Monday, November 11th. Wells Fargo & Company reduced their target price on shares of Mettler-Toledo International from $1,400.00 to $1,350.00 and set an “equal weight” rating for the company in a report on Monday, November 11th. Evercore ISI increased their price target on Mettler-Toledo International from $1,375.00 to $1,450.00 and gave the stock an “in-line” rating in a report on Tuesday, October 1st. JPMorgan Chase & Co. boosted their price target on shares of Mettler-Toledo International from $1,300.00 to $1,400.00 and gave the stock a “neutral” rating in a research note on Monday, August 5th. Finally, Robert W. Baird reduced their price objective on shares of Mettler-Toledo International from $1,375.00 to $1,310.00 and set a “neutral” rating for the company in a research report on Monday, November 11th. Two equities research analysts have rated the stock with a sell rating, five have assigned a hold rating and two have issued a buy rating to the company. According to data from MarketBeat.com, the company has an average rating of “Hold” and an average target price of $1,338.75.

Read Our Latest Stock Report on Mettler-Toledo International

Mettler-Toledo International Trading Up 0.8 %

Shares of MTD stock opened at $1,260.84 on Monday. The company has a market cap of $26.61 billion, a P/E ratio of 33.99, a PEG ratio of 4.13 and a beta of 1.16. The firm has a fifty day moving average price of $1,342.27 and a 200 day moving average price of $1,390.47. Mettler-Toledo International has a 12 month low of $1,068.33 and a 12 month high of $1,546.93.

Institutional Investors Weigh In On Mettler-Toledo International

Institutional investors and hedge funds have recently made changes to their positions in the business. PineStone Asset Management Inc. raised its position in Mettler-Toledo International by 127.4% during the second quarter. PineStone Asset Management Inc. now owns 259,629 shares of the medical instruments supplier’s stock worth $362,855,000 after acquiring an additional 145,453 shares during the last quarter. International Assets Investment Management LLC increased its stake in shares of Mettler-Toledo International by 149,870.0% during the 3rd quarter. International Assets Investment Management LLC now owns 89,982 shares of the medical instruments supplier’s stock worth $134,946,000 after purchasing an additional 89,922 shares in the last quarter. Massachusetts Financial Services Co. MA raised its position in shares of Mettler-Toledo International by 32.5% during the 2nd quarter. Massachusetts Financial Services Co. MA now owns 142,944 shares of the medical instruments supplier’s stock worth $199,777,000 after purchasing an additional 35,048 shares during the last quarter. Wellington Management Group LLP lifted its stake in Mettler-Toledo International by 17.5% in the 3rd quarter. Wellington Management Group LLP now owns 177,963 shares of the medical instruments supplier’s stock valued at $266,891,000 after buying an additional 26,443 shares in the last quarter. Finally, Barclays PLC grew its holdings in Mettler-Toledo International by 8.3% during the 3rd quarter. Barclays PLC now owns 256,602 shares of the medical instruments supplier’s stock valued at $384,822,000 after buying an additional 19,609 shares during the last quarter. 95.07% of the stock is currently owned by hedge funds and other institutional investors.

Insider Buying and Selling

In other Mettler-Toledo International news, Director Elisha W. Finney sold 76 shares of the company’s stock in a transaction on Monday, November 11th. The stock was sold at an average price of $1,311.75, for a total value of $99,693.00. Following the sale, the director now owns 240 shares of the company’s stock, valued at approximately $314,820. This represents a 24.05 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. 1.94% of the stock is owned by insiders.

Mettler-Toledo International Company Profile

(Get Free Report)

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company’s laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.

See Also

Earnings History and Estimates for Mettler-Toledo International (NYSE:MTD)

Receive News & Ratings for Mettler-Toledo International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mettler-Toledo International and related companies with MarketBeat.com's FREE daily email newsletter.